跳至主要内容
临床试验/NCT03071601
NCT03071601已完成4 期

Prospective Evaluation of Topical Analgesia Using a Lidocaine/Prilocaine Cream for Laceration Repair in the Emergency Department

Centre Hospitalier le Mans2 个研究点 分布在 1 个国家目标入组 132 人开始时间: 2017年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
132
试验地点
2
主要终点
Maximum pain

研究概览

简要总结

The purpose of this study is to determine if topical analgesia using a lidocaine and prilocaine cream improves pain scores compared to the usual local anesthesia using subcutaneous 1% lidocaine and adrenalin injected near the laceration.

详细描述

A prospective randomized open clinical trial conducted in two high volume emergency departments in France.

Adult patients presenting for laceration repair by suture will be allocated, after consent is obtained, on a one to one basis using a randomisation by minimisation method.

126 patients are expected to enrol in the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Superficial skin laceration requiring a suture

排除标准

  • Known allergy to lidocaine
  • Mucous membrane or eye wound
  • Nose, ear or perineal wound
  • Active hemorrhage in the wound
  • Dirty or infected wound
  • Wound requiring operation room management
  • Distracting pain in an other location
  • Intoxicated or comatose patient
  • Patient Under guardianship
  • Contra-indication to Lidocaine/Prilocaine cream: hypersensitivity, glucose-6-phosphate deficiency, idiopathic methemoglobinemia
  • Neurologic disorder affecting pain sensitivity
  • Pregnancy, breast feeding, absence of contraceptive measures for women of childbearing age
  • Absence of signed informed consent
  • Inclusion in an other interventional clinical protocol

研究组 & 干预措施

Topical anesthesia

Experimental

Topical anesthesia using a cream containing 2.5% Lidocaine and 2.5% Prilocaine applied for at least 30 minutes before laceration repair.

干预措施: Lidocaine-Prilocaine Cream 2.5-2.5% (Drug)

Subcutaneous injection anesthesia

Experimental

Local anesthesia by a subcutaneous injection of a solution containing 1% Lidocaine and 0.005 mg/mL Epinephrine in the minutes before laceration repair.

干预措施: Lidocaine 1% Epinephrine 0.005mg/mL solution (Drug)

结局指标

主要结局

Maximum pain

时间窗: 60 minutes

Maximum pain on the numerical pain scale (0-10) during laceration management (anesthesia, exploration and suture of the laceration).

次要结局

  • Patient satisfaction(60 minutes)
  • Management duration(60 minutes)
  • Wound healing(15 days)
  • Pain management during the various stages of care(60 minutes)
  • Topical anesthesia failure rate(60 minutes)
  • Adverse effects(15 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验